Indirect Treatment Comparisons of the Effect of Fedratinib Versus Navitoclax Plus Ruxolitinib on Spleen Volume and Symptoms in Patients with Myelofibrosis and Prior Ruxolitinib Treatment
- Resource Type
- Abstract
- Source
- In
Blood 23 November 2021 138 Supplement 1:4626-4626 - Subject
- Language
- ISSN
- 0006-4971